Cancer Genetics Awarded $1.8M from New Jersey Tax Program | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today said that it was awarded $1.8 million from New Jersey's Technology Business Tax Certificate Transfer program.

The program allows technology and biotechnology businesses with net operating losses to sell their unused net operating loss carryover and unused R&D tax credits for at least 80 percent of the value of the tax benefits to a profitable corporate taxpayer in New Jersey that is not an affiliated business. The $1.8 million awarded to Cancer Genetics is net of transaction costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.